rs727504600

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_002294.3(LAMP2):​c.121delT​(p.Cys41AlafsTer8) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. C41C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

LAMP2
NM_002294.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 5.70

Publications

2 publications found
Variant links:
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
LAMP2 Gene-Disease associations (from GenCC):
  • Danon disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-120456712-CA-C is Pathogenic according to our data. Variant chrX-120456712-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 179062.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMP2NM_002294.3 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 ENST00000200639.9 NP_002285.1 P13473-1
LAMP2NM_001122606.1 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 NP_001116078.1 P13473-3
LAMP2NM_013995.2 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 NP_054701.1 P13473-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMP2ENST00000200639.9 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 1 NM_002294.3 ENSP00000200639.4 P13473-1
LAMP2ENST00000434600.6 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 1 ENSP00000408411.2 P13473-3
LAMP2ENST00000371335.4 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 1 ENSP00000360386.4 P13473-2
LAMP2ENST00000706600.1 linkc.121delT p.Cys41AlafsTer8 frameshift_variant Exon 2 of 9 ENSP00000516464.1 A0A9L9PXQ4

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1080686
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
349648
African (AFR)
AF:
0.00
AC:
0
AN:
26137
American (AMR)
AF:
0.00
AC:
0
AN:
35051
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19203
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29989
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52164
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40142
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3347
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
829324
Other (OTH)
AF:
0.00
AC:
0
AN:
45329
GnomAD4 genome
Cov.:
22

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Danon disease Pathogenic:1
Aug 09, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Cys41fs variant in LAMP2 has not been reported in individuals with cardiomyo pathy or Danon disease or in large population studies. This frameshift variant i s predicted to alter the protein?s amino acid sequence beginning at position 41 and lead to a premature termination codon 8 amino acids downstream. This alterat ion is then predicted to lead to a truncated or absent protein. Loss of function of the LAMP2 gene is an established disease mechanism in males with Danon disea se. In summary, this variant meets our criteria to be classified as pathogenic ( http://pcpgm.partners.org/LMM) based upon the predicted impact to the protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.7
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727504600; hg19: chrX-119590567; API